Gossamer (GOSS) 2026 Earnings Outlook and Implications
Gossamer Bio's 2026 earnings outlook centers on cash runway, pipeline progress, and strategic partnerships. This arti...
Recognizing the warning signs of a flawed financial plan is essential. This article details indicators that signal the need for a financial review.
23,541 articlesGossamer Bio's 2026 earnings outlook centers on cash runway, pipeline progress, and strategic partnerships. This arti...
The NY Fed reports a rise in food insecurity, with more people going hungry now than during the COVID-19 crisis. The ...
Meta Platforms is advancing Arena, a stand-alone prediction markets app that would start with non-cash points and cou...
A 2024 business sale can push couples into IRMAA tiers in 2026. The two-year lookback means higher Medicare costs for...
Oracle shares slide as Larry Ellison funds a bid to steer a $110 billion media empire, triggering regulatory hurdles ...
When a company posts a robust quarter, insider stock moves often draw attention. This article unpacks the sale by the...
A booming memory era presents both opportunities and risks for Micron. This guide breaks down the potential, the cata...
Williams Companies positions its gas and power assets to benefit from the rapid expansion of AI data centers, signali...
Biotech stocks often ride a volatile wave of news, milestones, and insider moves. In the last year, one biotechnology...
An early-retiree couple saw their ACA premium credits evaporate after a single Roth conversion, revealing a hidden ta...
Rising coastal insurance costs are reshaping retirement plans as insurers reprice risk and pull back from high‑cost z...
Two very different tech plays collide in 2026: Innodata edges into AI data preparation, while Workiva anchors large e...